1. Home
  2. CULP vs FEMY Comparison

CULP vs FEMY Comparison

Compare CULP & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

N/A

Current Price

$3.21

Market Cap

43.8M

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.56

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
FEMY
Founded
1972
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
37.2M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CULP
FEMY
Price
$3.21
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
21.2K
462.5K
Earning Date
03-09-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.60
EPS
N/A
N/A
Revenue
$213,237,000.00
$1,629,108.00
Revenue This Year
N/A
$64.02
Revenue Next Year
$6.83
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
51.97
52 Week Low
$3.17
$0.31
52 Week High
$5.64
$1.76

Technical Indicators

Market Signals
Indicator
CULP
FEMY
Relative Strength Index (RSI) 33.04 49.50
Support Level N/A $0.53
Resistance Level $4.05 $0.57
Average True Range (ATR) 0.16 0.03
MACD -0.03 0.01
Stochastic Oscillator 9.62 72.56

Price Performance

Historical Comparison
CULP
FEMY

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: